Clearstead Trust’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
FLAM
DSCM
AIC
SM
RHJA
GIPM
Clearstead Trust's OPRX Position: Q1 2024 in Review
Clearstead Trust sold out of OptimizeRx (OPRX) in Q1 2024, closing a stake of 550 shares — an estimated $7.87K sold.
Clearstead Trust first reported a position in OPRX in Q2 2019 and held it in 19 quarters. The position peaked at $1.72M in Q3 2021. 97 funds tracked by Wall St. Rank hold OPRX as of Q1 2024.
- Clearstead Trust reported no remaining OptimizeRx position as of Q1 2024 after selling out during the quarter.
- Clearstead Trust sold 550 OptimizeRx shares in Q1 2024, an estimated $7.87K.
- Clearstead Trust first reported a position in OptimizeRx in Q2 2019 and held it in 19 quarters.
- Clearstead Trust's OptimizeRx position peaked at $1.72M in Q3 2021.
- 97 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2024.
Based on Clearstead Trust's 13F filing for Q1 2024, filed 10 May 2024.